Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 45Breast Neoplasms 20Myelodysplastic Syndromes 19Prostatic Neoplasms 12Neoplasms 12Leukemia, Myelomonocytic, Chronic 12Carcinoma, Hepatocellular 10Stomach Neoplasms 9Recurrence 9Carcinoma, Non-Small-Cell Lung 8Neoplasm Metastasis 7Uterine Cervical Neoplasms 6Sarcoma 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Ovarian Neoplasms 6Multiple Myeloma 6Esophageal Neoplasms 6Myeloproliferative Disorders 5Melanoma 5Lymphoma, Non-Hodgkin 5Lymphoma, B-Cell 5Lung Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Pancreatic Neoplasms 4Myelodysplastic-Myeloproliferative Diseases 4Leukemia, Biphenotypic, Acute 4Leukemia 4Esophageal Squamous Cell Carcinoma 4Colorectal Neoplasms 4Cholangiocarcinoma 4

Interventions

enzalutamide 4abiraterone 2Radiotherapy 2Metastasectomy 2Abiraterone Acetate 2testosterone enanthate 1pembrolizumab 1Radium-223 1Radiosurgery 1Prednisone 1Ketoconazole 1Injections 1Hydrocortisone 1Flutamide 1Crizotinib 1Control Groups 1Carboplatin 1Calcitriol 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Castration-resistant Prostate Cancer × Injections × Clear all
NCT06343038 2024-08-14

PROGNOSTICS

University Hospital, Basel, Switzerland

Phase 1 Recruiting
25 enrolled
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡